Alembic Pharma

APLLTD30 Apr 2024
Pharmaceuticals
+2.75 (+0.28%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Alembic Pharma
Alembic Pharma
Pharmaceuticals
APLLTD30 Apr 2024
+2.75 (+0.28%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Alembic Pharma - Share Price & Details

Lowest Today
984.75
Highest Today
1009.8
Today’s Open
991
Prev. Close
996.85
52 Week High
1094
52 Week Low
542.4
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
78.02%
Upper Circuit
Lower Circuit
P/E TTM
32.92
P/B Ratio
4.37
Traded Value(Cr)
0.00
EPS TTM
30.28
Book value
Dividend
0.80%

Price Performance

6.31 %
1 Wk
-0.93 %
1 M
10.92 %
3 M
78.02 %
1 Y
30.51 %
YTD

Traded Volume Movement

Technical Details

Support 3
962
Support 2
973
Support 1
987
Pivot Point :
999
Resistance 1
1012
Resistance 2
1024
Resistance 3
1037

Reports

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Alembic Pharmaceuticals Ltd
₹999.60(+2.75/0.28%)
999.60+2.7519,648.4578.0232.924.37
Lupin Ltd
₹1,645.90(+8.45/0.52%)
1,645.90+8.4575,011.91132.2136.393.89
Ipca Laboratories Ltd
₹1,339.50(+5.50/0.41%)
1,339.50+5.5033,983.6889.1061.695.47
J B Chemicals & Pharmaceuticals Ltd
₹1,905.25(-1.40/-0.07%)
1,905.25-1.4029,568.4983.2058.3711.01
Sanofi India Ltd
₹8,325.55(+48.05/0.58%)
8,325.55+48.0519,173.7453.4132.4618.88
393.70-2.802,311.24-3.8713.461.46

About Alembic Pharmaceuticals Ltd

Alembic Pharmaceuticals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 19592.43 crores. It has reported a sales of Rs. 1588.39 crores and a net profit of Rs. 233.24 crores for the quarter ended December 2018. The company management includes Chirayu R Amin, Chirayu R Amin,Pranav N Parikh,K G Ramanathan,Paresh Saraiya,Rajkumar Baheti,Pranav Amin,Shaunak Amin,Archana Hingorani,Ashok Barat,Manisha Saraf,Jai S Diwanji (Alembic Pharmaceuticals Ltd) among others.
Chairman
Chirayu R Amin
Registered office
Alembic Road,,Vadodara,Gujarat,390003
FAX :91-0265-2282506
Background
Incorporation Year2010
Face Value₹2
Market Lot1

Latest News

General Elections 2024: Will Nifty50 extend gains for 4th month in May?
With the general elections 2024 ongoing and the hopes of the incumbent PM Modi retaining office for the third term, Indian markets are likely to extend gains, giving positive returns for the fourth straight month in May. Moreover, improved macro data, continued foreign investor inflows, decent March quarter earnings and overall positive global trends will also aid investor sentiment this month.
01 May 2024 | 11:10 AM
Poonawalla Fincorp Q4 Results: profit rise by 67.21% YOY
Poonawalla Fincorp Q4 Results Live : Poonawalla Fincorp declared their Q4 results on 29 Apr, 2024. The topline increased by 1239.09% & the profit increased by 67.21% YoY. Compared to the previous quarter, the revenue grew by 19.98% and the profit increased by 25.1%.The Selling, general & administrative expenses rose by 3.64% q-o-q & increased by 3102.31% Y-o-Y.
01 May 2024 | 11:12 AM
General Elections 2024: Will Nifty50 extend gains for 4th month in May?
With the general elections 2024 ongoing and the hopes of the incumbent PM Modi retaining office for the third term, Indian markets are likely to extend gains, giving positive returns for the fourth straight month in May. Moreover, improved macro data, continued foreign investor inflows, decent March quarter earnings and overall positive global trends will also aid investor sentiment this month.
01 May 2024 | 11:10 AM
Gillette India Q3 Results: profit falls by 3.52% YOY
Gillette India Q3 Results: Gillette India declared their Q3 results on 29 Apr, 2024. The topline increased by 9.96% & the profit decreased by 3.52% YoY. As compared to the previous quarter the revenue grew by 6.46% and the profit decreased by 4.68%. The Selling, general & administrative expenses declined by 8.18% q-o-q & decreased by 12.55% Y-o-Y. The operating income was up by 3.4% q-o-q.
01 May 2024 | 11:00 AM
Aurum Proptech Q4 Results: loss falls by 22.6% YOY
Aurum Proptech Q4 Results: Aurum Proptech declared their Q4 results on 29 Apr, 2024. The topline increased by 31.83% & the loss decreased by 22.6% YoY. Compared to the previous quarter, the revenue grew by 4.36% and the loss decreased by 75.61%. The Selling, general & administrative expenses declined by 56.14% q-o-q & decreased by 26.52% Y-o-Y. The operating income was up by 76.88% q-o-q.
01 May 2024 | 10:59 AM

How to buy Alembic Pharma shares on nse?

To buy Alembic Pharma shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Alembic Pharma share price today?

The Alembic Pharma shares price on nse is Rs.999.6 today.

What is the market cap of Alembic Pharma shares on NSE ?

The company has a market capitalization of Rs.19648.45Cr

What is the PE & PB ratio of Alembic Pharma shares ?

PE is 32.92 and PB is 4.37

What is the 52 Week High and Low of Alembic Pharma shares?

Alembic Pharma stock price high: Rs.1094 Alembic Pharma stock price low: Rs.542.4

How can I purchase stock in Alembic Pharma?

You can use the services of a reliable broker like Motilal Oswal to purchase stock in Alembic Pharma. All you have to do is sign up with the broker and open demat and trading accounts. You can buy stocks in Alembic Pharma on the stock exchange through the broker. 

 

Is Alembic Pharma a good investment?

According to some analysts, Alembic Pharma is an undervalued stock at present. Still, it may be a good investment if you are thinking of a long-term view as the stock may see an upside in the future. 

Is Alembic Pharma debt-free?

In September 2022, Alembic Pharma held debt at approximately Rs. 7.71 billion, down from the previous year. 

What is the dividend yield of Alembic Pharma?

The dividend yield of Alembic Pharma is 2.09% (March 2022).